Pharmacy retail chain MedPlus plans entry into Mumbai in next 3 months

Medplus has its largest presence in South India and is now expanding in western region with stores in Pune and Nagpur

The company already enjoys a 67-68 per cent share of the respiratory drugs market in India and has potential for a 14-15 per cent growth
Aneesh Phadnis Mumbai
2 min read Last Updated : Sep 18 2019 | 9:22 PM IST
Pharmacy chain MedPlus, which recently raised Rs 200 crore from Wipro Chairman Azim Premji's family office, Premji Invest, will enter the Mumbai market within the next three months.

Founded by doctor-turned-entrepreneur Madhukar Gangadi, MedPlus is the country's second largest pharmacy chain with around 1,700 stores. It has its largest presence in South India and is now expanding into the western region with stores in Pune and Nagpur.

"Each year we open around 100-150 stores. We plan to launch in Mumbai within the next three months as part of the expansion," Gangadi said. He added that the company aims to have 30-40 stores in Mumbai and added the chain was not looking at acquisitions for growth.

Gangadi said his company has been able to face the challenge from e-pharmacies as it has a better value proposition in both drug availability and discounts. He, however acknowledged margins were under pressure due to higher discounts this year.

"We aim to end the current financial year with a revenue of Rs 2,700-2,800 crore and an earning before interest tax and depreciation of aound Rs 70-75 crore. We have an omni-channel presence and get around 17 per cent of our business from our online platform," he added. MedPlus, which began with a single store in Hyderabad in 2006, operates a hub-and-spoke model with its own warehouses serving as stores.

Last year, Gangadi raised around Rs 700 crore from Goldman Sachs to buy out existing private equity investors, a media report had said. US e-commerce giant Amazon had shown interest in picking up a stake in the company last year but Gangadi said there was no serious discussion with it for a stake sale.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :MedPluspharmacyonline pharmacyOnline pharma

Next Story